Study how HPV changes affect outcomes in CIN2
Part of Cancer, Infections, Women’s health & pregnancy clinical trials.
This study follows women with an early abnormal cervix cell change (CIN2/CIN2-3) to see how HPV DNA “integration” relates to whether the condition improves or worsens. It may help doctors better predict prognosis and guide safer monitoring, especially if you want to become pregnant.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 to 45 years old and want to become pregnant (or are trying).
- You were diagnosed with CIN2 (or CIN2-3) by biopsy within the last 3 months.
- You have not had cervical surgery or medicine treatment for this condition yet.
- Your biopsy scan (colposcopy) shows the abnormal area is under 50% of the cervix.
- You can and agree to be followed for 12 months without treatment unless the condition worsens.
- You are not pregnant or breastfeeding.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks for ways to predict who will respond to imiquimod cream for precancerous cervical cell changes (CIN2 or CIN3). Results may help doctors choose the best treatment approach and better plan follow-up.
This trial checks whether “therapy abstention” (not treating right away) and close monitoring is safe for certain high-grade cervical cell changes. It may help some people avoid immediate procedures while still catching any progression early.
This study tests ways to improve cervical cancer screening for women ages 30–65. It may help catch cervical cancer early or prevent it entirely by finding precancerous changes.
This study tests a special light-based treatment (called HAL-PDT) for early cervical changes (CIN2) that were found on a recent biopsy. The goal is to see if this treatment can safely remove these changes and prevent them from becoming cancer.
This trial tests whether an HPV vaccine (the nonavalent type) can help prevent the same precancerous lesions from coming back after treatment. It is for people who currently have a high-grade HPV-related lesion but have not yet been treated for it.
This Phase 2 study tests whether a curcumin (a natural plant compound) cream/gel applied to the cervix can help treat cervical cell changes linked to HPV. It focuses on people with mild (LSIL) or recently treated severe (HSIL) precancer changes, aiming to reduce disease and improve healing.
Hear when a new Cervical Intraepithelial Neoplasia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.